The homodimeric flavoenzyme glutathione reductase (GR) maintains high intracellular concentrations of the antioxidant glutathione (GSSG ؉ NADPH ؉ H ؉ 7 2 GSH ؉ NADP ؉ ). Due to its central function in cellular redox metabolism, inhibition of GR from the malarial parasite Plasmodium falciparum represents an important approach to antimalarial drug development; therefore, the catalytic mechanism of GR from P. falciparum has been analyzed and compared with the human host enzyme. The reductive half-reaction is similar to the analogous reaction with GR from other species. The oxidative halfreaction is biphasic, reflecting formation and breakdown of a mixed disulfide between the interchange thiol and GSH. The equilibrium between the E ox -EH 2 and GSSG-GSH couples has been modeled showing that the Michaelis complex, mixed disulfide-GSH, is the predominant enzyme form as the oxidative half-reaction progresses; rate constants used in modeling allow calculation of an K eq from the Haldane relationship, 0.075, very similar to the K eq of the same reaction for the yeast enzyme ( 
The glutathione disulfide/glutathione (GSSG/GSH) redox couple is present in most eukaryotic cells at millimolar concentrations (1) . Major functions of GSH include the detoxification of reactive oxygen species by donation of reducing equivalents to glutathione peroxidase and glutathione S-transferase as well as enzyme regulation by thiol-disulfide interchange reactions (2) . The flavoenzyme glutathione reductase (GR, 1 EC 1.6.4.2) catalyzes the reduction of GSSG to GSH and creates an intracellular GSH/GSSG ratio of 20 to 1000 depending on the respective metabolic conditions (3) . Thus, glutathione reductase, a protein of 2 ϫ 55 kDa, plays a key role in cellular redox homeostasis. Both human GR (hGR) and Plasmodium falciparum GR (PfGR) are essential for the survival of the malarial parasite within the human erythrocyte (4, 5) . The amino acid sequence identity between the two enzymes is 45% with two major features distinguishing them: (i) an insertion of 34 amino acids within the central domain (residues 318 -351) between the FAD binding motif and the highly conserved H8 helix (6) ; (ii) the differences in the amino acid residues lining the wall of the interface cavity, where only 8 out of 25 residues are conserved in PfGR. This cavity represents the binding site of many inhibitors including isoalloxazines, safranine, and menadione in human GR and could be the binding site of methylene blue in PfGR (7) .
Glutathione reductase belongs to the pyridine nucleotidedisulfide oxidoreductase family of homodimeric flavoenzymes that includes lipoamide dehydrogenase and thioredoxin reductase. Like other members of this family, each subunit of GR contains a disulfide and a flavin that are in redox contact. This ground state of the enzyme is referred to as E ox . In the twoelectron-reduced enzyme (EH 2 ) at equilibrium, a rather stable charge transfer complex predominates between one of the nascent thiolates, referred to as the charge transfer or proximal thiolate as the donor, and the flavin, as the acceptor (8) . This species can be distinguished from the oxidized (E ox ) and fully reduced enzyme (EH 4 ) by its absorbance around 540 nm. The other nascent thiol in EH 2 is referred to as the interchange or distal thiol and initiates the dithiol-disulfide interchange with glutathione disulfide that involves a mixed disulfide (MDS) between glutathione and the interchange thiol (7, 9 -11) .
Physiologically, E ox is reduced by NADPH via the flavin to give EH 2 . The several steps of this electron transfer constitute the reductive half-reaction (Scheme 1). This is followed by an NADP ϩ -NADPH exchange when NADPH is in excess. EH 2 then reacts with the second substrate, glutathione disulfide, yielding two molecules of reduced glutathione in the oxidative half-reaction. As previously shown for hGR and the yeast en-zyme, a mixed disulfide is an intermediate in the oxidative half-reaction (Scheme 2) (11). Evidence for the mixed disulfide was provided by x-ray crystallography using hGR crystals soaked with glutathione (7, 10) , by chemical identification (12) , and by spectral studies (11) . In kinetic studies MDS has been elusive so far (see below).
Since drug resistance of malarial parasites as well as the geographical distribution of malaria is increasing, new therapeutic approaches are urgently required. Indeed it is clear from the current secular press that global warming, resulting in malaria moving north, has put this disease into the awareness of the "First World." PfGR represents a potential target of drugs against malaria. The best known lead compound in this context is the antimalarial agent methylene blue, which has been demonstrated to be a specific inhibitor of PfGR (13) and does not affect the human enzyme at therapeutic concentrations. The x-ray structure of the methylene blue-PfGR complex has not yet been solved. The most probable binding site for methylene blue is the intersubunit cavity of the enzyme. The hGR, on the other hand, is arguably the most thoroughly studied flavoenzyme by x-ray crystal methods (7) .
To develop parasite-specific drugs it is essential to understand and compare kinetic, functional, and structural properties of parasite and host cell enzymes and to identify the enzyme species that predominate in vivo, therefore serving as antiparasitic drug targets. In the present study we have investigated the reductive and oxidative half-reactions of PfGR. With the aid of computer simulation programs, we offer the first kinetic evidence for the MDS form. Furthermore, we studied the protein in enzyme-monitored turnover and characterized enzyme intermediates that can be considered as targets of syncatalytic inhibitors. Some of these intermediates such as EH 2 ⅐NADPH and the newly identified MDS are likely to occur in the cytosol of parasites that are not challenged by reactive oxygen species. Under these conditions, most cytosolic GR molecules are at equilibrium. EH 4 , containing both the flavin and the active site cysteine pair in the reduced form, was identified by reducing PfGR with NADPH under forcing conditions. Since the individual forms of the enzyme differ in their susceptibility to inhibitors, the characterization of these newly identified species is of high practical relevance.
EXPERIMENTAL PROCEDURES

Materials-Recombinant PfGR was expressed in Escherichia coli
SG5 cells and purified by affinity chromatography on 2Ј,5Ј-ADP-Sepharose as described previously (13) . GSH, GSSG, NADPH, Leuconostoc mesenteroides glucose-6-phosphate dehydrogenase, glucose 6-phosphate, methylene blue, dithionite, and all other reagents were obtained from Serva and Sigma. All reagents used were of the highest purity available.
Rapid Reaction Kinetics-The rapid reaction kinetics of the enzyme were measured under anaerobic conditions in a stopped flow spectrophotometer as described before (14) . Solutions were made anaerobic using alternating cycles of vacuum and nitrogen (15) . All reactions were performed in GR buffer containing 47 mM potassium phosphate, 200 mM KCl, and 1 mM EDTA, pH 6.9, at 4°C. After mixing, the PfGR concentration varied between 15 and 22 M. The data were analyzed by curve-fitting either to a single or to multiple exponential functions (16) , pH 6.9, oxidation was started by mixing with GSSG (17) . The free acid form of GSH used in these experiments was dissolved in anaerobic GR buffer and then titrated to pH 6.9 using 1 M NaOH. Quantitation of the thiol titer was determined using 5,5Ј-dithiobis(2-nitrobenzoic acid). The content of GSSG in the GSH stock solutions varied from batch to batch between 0.5 and 1%. To anaerobic solutions of 1 eq of GSSG, varied amounts of anaerobic GSH were added. These GSSG/GSH solutions were mixed rapidly with the reduced PfGR, and the spectral changes were followed in the stopped flow for all regions of interest.
The NADPH-regenerating System-For experiments where constant NADPH concentrations were required, an NADPH-regenerating system consisting of glucose-6-phosphate dehydrogenase (G6PDH) and glucose 6-phosphate (G6P) was employed. For the titration experiment, the anaerobic cuvette contained 5 mM G6P and 5 units/ml G6PDH (at 25°C), the NADPH concentration in the side arm being 25 M. For stopped flow experiments the G6PDH activity was raised to 1000 units/ml.
RESULTS
Spectral
Characteristics of PfGR-The spectral properties of the enzyme species detected with PfGR are summarized in Table I , which is patterned after a similar table in KrauthSiegel et al. (18) . During the reductive half-reaction with excess NADPH, E ox is reduced to EH 2 (FAD)(SH) 2 ⅐NADPH via the four intermediates shown (Table I , top to bottom). EH 2 is thus a mixture of several forms; the predominant species is the thiolate-flavin charge transfer complex, EH 2 (FAD)(SH) 2 . EH 2 (FAD)(SH) 2 forms complexes with NADPH and NADP ϩ . The spectral characteristics of the charge transfer complexes and the four-electron-reduced enzyme EH 4 at pH 6.9 were determined in the experiments described below and are essential for the interpretation of the pre-steady state kinetic results.
Anaerobic titration of PfGR with dithionite requires 1 eq/ FAD-containing subunit to give EH 2 (FAD)(SH) 2 and a second equivalent to form EH 4 (data not shown). As expected, there were no other redox active centers in PfGR. Titration of E ox with the physiological reductant NADPH leads to the EH 2 (FAD)(SH) 2 ⅐NADP ϩ charge transfer complex with a K d of less than 3 M; excess NADPH displaced the NADP ϩ (data not shown).
Reductive Half-reaction-Rapid reaction kinetics for the reductive half-reaction with NADPH revealed four distinct phases that could be detected at 440, 540, and 670 nm. The two faster steps were dependent on the NADPH concentration, the first being clearly attributable to FAD reduction (14) . Fig. 1 shows the spectra recorded during the reaction of the enzyme with 4 eq of NADPH. The first phase (spectra 1-3) is characterized by a decrease at 460 nm and an increase at wavelengths greater than 600 nm, which indicates formation of the
ϩ species is formed and partially degraded too rapidly for the full extent of its formation to be observed (14) . The phase giving rise to spectra 1-3 is easily distinguished from a slower kinetic process (spectra 4 -6), at the end of which the spectrum is typical of the EH 2 (FAD)(SH) 2 ⅐NADPH complex. This is reinforced by the presence of an isosbestic point at 620 nm, indicating that from 17 to 300 ms one enzyme species is being converted to another. The four phases were well resolved in the kinetic trace shown in the inset of Fig. 1 ; the rate constants are given in Table II and shown to be comparable SCHEME 1. SCHEME 2.
with those measured with the E. coli enzyme. The fourth phase, having a rate of 4 s Ϫ1 , was associated with a very small fraction of the total absorbance change; it may have been due to ongoing exchange of NADP ϩ by the excess of NADPH. Oxidative Half-reaction-Reduction of PfGR with borohydride led to the thiolate-flavin charge transfer complex, EH 2 (FAD)(SH) 2 , with its characteristic absorbance at 540 nm. During the subsequent oxidation with glutathione disulfide the absorbance at 540 nm decreased continuously, which is shown in the kinetic traces in Fig. 2A . The reaction appeared to be biphasic, and both rates were dependent on the GSSG concentration; the first phase was associated with up to 90% of the absorbance change and had a limiting rate of 236 s Ϫ1 (K d , app ϭ 346 M); the second phase had a limiting rate of 54 s
Chemical precedent shows that the reaction is composed of two steps, formation and breakdown of a MDS between glutathione and the interchange thiol of GR (11). However, the observed rates reflect combinations of rate constants and are not directly attributable to individual reactions (see modeling below). The fitted curves in Fig. 2A all tend to the same starting absorbance; the real data, starting at approximately 5 ms, began at continuously lower values as the GSSG concentration was raised. Since the formation of MDS involves only a small extinction change, this indicates that most of the MDS formation has taken place in the dead time; this is born out by the model (below). Thus, most of the observed reaction describes the breakdown of the MDS. Methylene Blue in the Reductive and Oxidative Half-reaction-PfGR is the only verified enzymic target of the antimalarial dye methylene blue (13, 19, 20) . The addition of 1-3 eq of inhibitor in the oxidative half-reaction did not affect the kinetic characteristics of the reaction. The reductive half-reaction, however, appeared to be altered in the presence of the inhibitor, but priorities for the limited enzyme precluded further study of the effect.
Spectral Characteristics of the Mixed Disulfide-The mixed disulfide had been predicted in earlier work (9) . Direct evidence for this species was provided by x-ray crystallography using GR crystals soaked with glutathione (7, 10) and by chemical modifications (12) . The MDS was assumed to provide a promising target for rational drug design (7) . The spectral characteristics of the MDS of yeast GR have recently been described (11) . Evidence for the MDS between the interchange thiol of the enzyme (Cys-58) and glutathione could be observed readily when GSH is included together with the GSSG in the oxidative half-reaction. EH 2 was no longer quantitatively oxidized by GSSG to E ox as in the absence of GSH, because an intermediate, attributed to the mixed disulfide, accumulates. The kinetic traces observed at several concentrations of GSH are shown in Fig. 2B and compared with the kinetics observed in the absence of GSH.
The MDS was found to have a lower thiolate-flavin charge transfer absorbance and a higher 462 nm/492 nm ratio than seen in EH 2 (FAD)(SH) 2 . As more GSH was added to the oxidative half-reaction, breakdown of the MDS was retarded, and more MDS accumulated. Fig. 3 shows the change in the 462 nm/492 nm ratio as the reaction of EH 2 (FAD)(SH) 2 (ratio of approximately 1.34) with GSSG progressed to the MDS (ratio of approximately 1.42) in the presence of GSH and to E ox (ratio of approximately 1.26) in the absence of GSH.
Analysis of the spectra of the enzyme species formed during the oxidative half-reaction by singular value decomposition revealed three eigenvectors when GSH was included in the reaction mixture, whereas in the absence of GSH, only two significant eigenvectors were observed, representing E ox and EH 2 (FAD)(SH) 2 ; the third eigenvector that developed in the presence of GSH was attributed to the MDS. Since the formation of MDS from EH 2 (FAD)(SH) 2 involves a small absorbance change and MDS breakdown to E ox involves a large absorbance change, the isosbestics at 355, 390, 450, and 508 nm, observed for interconversion of E ox and EH 2 (FAD)(SH) 2 , are not expected in the spectra of the MDS approximated by singular value decomposition. The approximations are given in Fig. 4 for three concentrations of GSH.
Modeling of Equilibria Important in the Oxidative Half-reaction-A model for the kinetic equilibrium between the E ox -EH 2 and the GSSG-GSH redox couples is presented in Scheme 3. The reaction has been simulated in the direction of EH 2 (FAD)(SH) 2 oxidation by GSSG using the set of rate constants shown in Table III ; the extinction coefficients at 540 nm of the enzyme forms were held constant in the simulations: EH 2 (FAD)(SH) 2 ϭ 3000; MDS ϭ 2650; E ox ϭ 535 M Ϫ1 cm Ϫ1 . The quality of the simulation is shown in Fig. 5A and can be compared with the fitted curves shown in Fig. 2A. Fig. 5B shows the mole fractions of the six species as the reaction of EH 2 (FAD)(SH) 2 with 40 eq of GSSG progresses. It can be seen that MDS⅐GSH is the predominant intermediate; it represents 48% at 3.4 ms; the reaction reaches equilibrium at approximately 50 ms and is essentially complete with 95% E ox and no detectable EH 2 (FAD)(SH) 2 . If EH 2 (FAD)(SH) 2 is reoxidized by stoichiometric GSSG in the presence of excess GSH, MDS⅐GSH remains the predominate intermediate, 46% at 250 ms when the reaction has reached equilibrium with 4% E ox and 33% EH 2 (data not shown). The results are predicted by the model since MDS⅐GSH precedes the rate-limiting step in which the first molecule of GSH dissociates with a rate constant, k 5 ϭ 250 s Ϫ1 . The simulations of the experiments with added GSH (Fig. 5A , curves 7 and 8) are not as good as the others (curves 1-6 ). The limiting observed rate of 236 s Ϫ1 is associated with up to 90% of the A 540 nm disappearance and probably reflects the breakdown of the MDS limited by the dissociation of the first molecule of GSH (Table II) . The limiting observed rate of 54 s Ϫ1 , involving as little as 10% of the A 540 nm disappearance, is not easily associated with a chemical step in the model. Fitting the A 540 nm to 2 exponentials assumes a simple A to B to C model and should not be compared with the more complete A to C to D to E to G to H model of Scheme 3.
The reaction has also been simulated in the opposite direction using data from the reduction of E ox by GSH and the rate constants in Table III . The quality of the simulation is shown in Fig. 5C . GSH dissociation from MDS is set at 250 s Ϫ1 in both simulations, and it can be argued that there is no reason that the dissociation of GSH from MDS (k 5 ) or from E ox (k 9 ) should be the same because different binding sites ( 1 GSH and 2 GSH) are involved (10) . Fig. 5D shows the mole fractions of the six species as the reaction of E ox with 100 eq of GSH progresses. It can be seen that MDS⅐GSH is the major intermediate; MDS⅐GSH and the product, EH 2 (FAD)(SH) 2 , are both present at approximately 35% at 1 s, when the reaction has reached equilibrium. Again, the model predicts the buildup of MDS⅐GSH, since this intermediate precedes the rate-limiting step, k 4 , of 12 s Ϫ1 . Enzyme-monitored Turnover-To determine the predominant PfGR species under turnover conditions in the cell, PfGR was monitored during in vitro turnover under quasi-physiological conditions. The kinetic traces at 460 nm for three experiments are shown in Fig. 6A : NADPH with excess GSSG in the absence of GSH (curve 1), NADPH, and GSSG at equal concentrations in the absence and presence of GSH (curves 2 and 3). Three major phases can be distinguished during the reaction: PfGR reduction with NADPH, steady state turnover, and reoxidation by GSSG. After PfGR reduction, turnover continued until NADPH was used up by GSSG. The spectrum acquired just before turnover is spectrum 2 in Fig. 6B . It seems to represent a mixture of two enzyme species, namely (i) EH 2 (FADH Ϫ )(S-S)⅐NADP ϩ , which is indicated by the long wavelength band at 680 nm, and (ii) the EH 2 (FAD)(SH) 2 ⅐NADPH complex as indicated by the increased absorbance due to the thiolate-flavin charge transfer complex at 540 nm (Table I ). These two enzyme species are involved in the rate-limiting step of the reductive half-reaction, namely the transfer of reducing equivalents from FAD to form the dithiol. As the reaction progresses into turnover, the latter enzyme species becomes predominant (spectrum 3 in the presence of GSH and spectrum 4 in its absence).
EH 4 as a Possible Enzyme Species in Vivo-
The high NADPH concentration in many cells is due to the action of NADPH-regenerating enzymes such as glucose-6-phosphate dehydrogenase. The G6PDH/G6P system was used in a static experiment to reduce PfGR. In such an experiment, the concentration of NADP ϩ was vanishingly low as it was constantly Fig. 2 . Circles, no GSH added; triangles, 0.2 mM GSH added; squares, 1.0 mM GSH added; diamonds, 2.0 mM GSH added .   FIG. 4 . Spectra derived for the mixed disulfide during reoxidation by GSSG in the presence of GSH using singular value decomposition. Dots, 0.2 mM GSH; dash-dot, 1 mM GSH; solid line, 2 mM GSH. The model used was: EH 2 3 MDS 3 E ox . Curves 1 and 5 represent EH 2 (FAD)(SH) 2 and E ox , respectively. SCHEME 3.
reduced to NADPH by G6PDH, resulting in a high ratio of NADPH/NADP ϩ . In contrast to a simple titration with NADPH, E ox is not only reduced to EH 2 but slowly to EH 4 , the fully reduced species of PfGR (Fig. 6B, curve 7) , suggesting that EH 4 could be formed under cellular conditions (see below).
DISCUSSION
Rapid Reaction Studies-Spectral characteristics of PfGR during the reductive half-reaction indicate the formation of an enzyme species with reduced flavin and bound NADP ϩ followed by a rate-limiting electron transfer to the redox active disulfide; exchange of NADPH for NADP ϩ may be concomitant with electron transfer (Scheme 1 and Fig. 1 ), similar to the same reaction in the E. coli GR (14) . The reductive half-reaction takes place in four phases; the first two rates are similar and dependent on the NADPH concentration. A very preliminary model of the reactions in Scheme 1 indicates that the observed characteristics of the reductive half-reaction are reasonable. A more complete model of the reductive half-reaction of the related enzyme, thioredoxin reductase from E. coli, was followed (21) . These results are qualitatively identical and quantitatively similar to the reductive half-reaction of GR studied in other species (Table II) .
The two phases observed in the oxidative half-reaction cannot be related directly to chemical steps, as mentioned under "Results" (Fig. 2 and Table II ). The two chemical steps in the oxidative half-reaction represent (i) the formation of a mixed disulfide between GSH and the interchange thiol of the enzyme active site with concomitant release of the first molecule of GSH, followed by (ii) the breakdown of this intermediate to form E ox and the second GSH (Scheme 3, Figs. 3-5 , Table III ). The spectral properties of this intermediate have been studied in the yeast enzyme during reoxidation of EH 2 by GSSG in the absence and presence of GSH, revealing a high ratio of absorbance at 462 nm to that at 492 nm (11); PfGR has essentially the same ratio (Fig. 3) . The spectral properties of the MDS approximated in Fig. 4 are like those of yeast GR having an extinction at 540 nm almost as high as that of the thiolate-flavin charge transfer complex (11) . Considering the high physiological GSH Table III ; B, the mole fractions of EH 2 (FAD)(SH) 2 (dash dot dot), EH 2 ⅐GSSG (long dash), MDS⅐GSH (dots), MDS (dash dot), E ox ⅐GSH (short dash), and E ox (solid line) as the reaction with GSSG progresses; C, the data from the reaction of 31 and 104 eq of GSH with E ox were simulated according to the model using the rate constants of Table III ; D, the mole fractions of E ox , the four intermediates, and EH 2 (FAD)(SH) 2 are shown as the reaction of E ox with GSH progresses (same symbols as in B).
FIG. 6. Enzyme monitored turnover by P. falciparum glutathione reductase. A, 12.9 M PfGR at 4°C in 47 mM KP i , 200 mM KCl, 1 mM EDTA, pH 6.9, was reduced by 100 M (curve 1) or 300 M (curve 2) NADPH in the presence of 300 M GSSG. Curve 3, 300 M NADPH in the presence of 300 M GSSG plus 1 mM GSH. B, conditions as in A, curve 1, E ox ; curve 2 after 2.5 ms (the discontinuity at ϳ560 nm is due to the sequence of diode array read-out); curve 3, averaged after ϳ40 -80 ms, 300 M NADPH in the presence of 300 M GSSG plus 1 mM GSH; curve 4, as in 3, no GSH added; curve 5, 2 s, no GSH added; curve 6, 2 s, 1 mM GSH. Curve 7, a separate static experiment in which 21.5 M enzyme was reduced at 25°C with an NADPH-regenerating system consisting of approximately 5 units of L. mesenteroides glucose-6-phosphate dehydrogenase, 5 mM glucose 6-phosphate, and 25 M NADPH.
concentration, it is suggested that MDS represents an important physiologic species in the catalytic cycle. It should be noted that this is the first glutathione reductase in which a MDS has been suggested by the kinetic data; consequently, earlier data can now be reexamined (14) . Table II summarizes what is known about the oxidative half-reaction of GR from the four best-studied species.
The kinetic equilibrium between the E ox -EH 2 and the GSSG-GSH redox couples has been modeled as presented in Scheme 3 and Table III . The model allows semi-quantitative simulations demonstrating that MDS appears and exists in significant quantities under normal cellular conditions (Fig. 5) . MDS⅐GSH, the enzyme form preceding the rate-limiting step of product dissociation, accumulates as oxidation progresses (Fig. 5B) . In the reduction of E ox by GSH, MDS⅐GSH accumulates where the rate-limiting step is either proton capture by the enzyme base (His-484) or attack of the resulting glutathione thiolate on the MDS to form GSSG.
The overall equilibrium constant in the direction of EH 2 reoxidation by GSSG can be calculated from the Haldane relationship using the same kinetic constants (Table III) . K Haldane ϭ k 1 ⅐k 3 ⅐k 5 ⅐k 7 ⅐k 9 /k 2 ⅐k 4 ⅐k 6 ⅐k 8 ⅐k 10 ϭ 0.075. This number is very similar to the equilibrium constant of the same reaction for the yeast enzyme (0.085), arrived at by modeling equilibrium (rather than kinetic) data (11) . We contend that this correspondence lends considerable credibility to the model. With this K Haldane , the redox potential of the E ox /EH 2 couple for PfGR was calculated as Ϫ206 mV at pH 6.9 and 4°C. The simulations do not correlate exactly with the data; one or more additional steps should be considered, e.g. proton associations or dissociations that were shown to be important in modeling equilibrium data with yeast glutathione reductase.
The reaction of PfGR with NADPH and GSSG in the absence and presence of GSH was investigated by enzyme-monitored turnover to determine the predominant PfGR forms under conditions of turnover in the cell. It was found that two species were present at high concentrations, EH 2 (FADH Ϫ )(S-S)⅐NADP ϩ , early in the turnover phase, and EH 2 (FAD)(SH) 2 ⅐NADPH, as turnover progressed. This is an expected result since these are the two enzyme forms (reactant and product, respectively) involved in the rate-limiting step of the reductive half-reaction. During the short period of steady state turnover, the averaged spectra were approximately the same in the absence and presence of GSH (cf. Fig. 6,  curves 3 and 4) . This suggests that under physiological conditions of high GSH concentrations, the distribution of enzyme intermediates is not affected.
EH 4 may be a relevant species in the presence of a high NADPH to NADP ϩ ratio maintained in vivo by G6PDH. In erythrocytes, the physiological activity of G6PDH is high, approximately 10 units/g of Hb (22) . EH 4 is not, however, an intermediate in catalysis (23) . A significant fraction of EH 4 forms in vitro under conditions that approximate those in the cell (curve 7, Fig. 6 ). Two factors influence the equilibrium to produce the following interesting result. (i) The redox potentials of EH 2 /EH 4 , Ϫ325 mV for the E. coli and human enzymes, (24) and of NADP ϩ /NADPH, Ϫ309 mV at pH 6.9 and 25°C (25), together with the high NADPH concentration determine the effective redox potential of the system; (ii) the binding of NADPH to EH 2 is very tight, and we assume that it is tighter than the binding to EH 4 ; this causes the redox potential of the system to be shifted to even more negative values (26) . The high ratio of NADPH to NADP ϩ evidently prevails to allow reduction of EH 2 to EH 4 . EH 4 is much more sensitive to proteolytic inactivation than any other GR species (27) . These facts taken together make it possible that EH 4 has a biological function in glutathione reductase metabolism but not in catalysis. Being a "standby" form of the enzyme, EH 4 is therefore significant as a drug target.
The Different Glutathione Reductase Species as Drug Targets in Vivo-The results of our studies indicate that PfGR qualitatively resembles GRs from other species but that the quantitative differences may be exploited for the rational design of antimalarial drugs. The urgent need for a new generation of drugs has already been mentioned. As shown under "Results," the newly identified GR species MDS and MDS⅐GSH occur under physiologic conditions, and EH 4 is observed under forcing conditions. This allows us for the first time to consider the states of GR that may prevail in the cell. Since the individual forms of the enzyme differ in their susceptibility to inhibitors, this question is of practical relevance. It will be of special interest to study compounds like methylene blue and isoalloxazines, which bind to all forms of the enzyme (27) but appear to exert their effects on specific steps of the catalytic cycle. As reported here, methylene blue interferes with the reductive half of the PfGR-catalyzed reaction but has no effect on the oxidative half-reaction.
Agents like the cytostatic drug carmustine, ajoene, and nitric oxide derivatives attack only glutathione reductase species with a free interchange thiol such as EH 2 (FAD)(SH) 2 . For carmustine (which is also active against rodent malaria), the modification of GR has been shown to occur also in vivo (28, 29) . Indeed EH 2 (FAD)(SH) 2 and its complex with NADPH appear to be the predominant intracellular PfGR forms. As shown in Figs. 1 and 6, these EH 2 -forms have the longest life time during the catalytic cycle and would, thus, be accessible to the attack of electrophilic drugs.
Our data also suggest that EH 2 (FAD)(SH) 2 occurs as the major standby form of the enzyme in vivo. P. falciparum has a GR capacity of 10 mM/min, that is, far in excess of normal metabolic needs (30) . At any given moment, the major part of intracellular PfGR molecules are maintaining a steady state in which net substrate is not turning over, and the redox state of the stand-by forms of the enzyme is determined by the intracellular concentrations of substrates and products. For concentrations of metabolites in cytosolic spaces, the human erythrocyte may be regarded as representative. This cell contains 1-2.5 mM GSH and 10 -50 M GSSG (22, 31) . The total concentrations of NADPH and NADP ϩ , respectively, are 32 and 1.4 M; however, the major part of the pyridine nucleotides is complexed by proteins so that the free concentrations are only 2.1 M NADPH and 0.5 M NADP ϩ (32). Consistent with our results, these intracellular conditions favor EH 2 (FAD)(SH) 2 and its complex with NADPH as predominant species of the enzyme in normal steady state turnover.
Drastic changes of the pyridine nucleotide and glutathione levels occur during cell differentiation (33) and under pathophysiological conditions. Examples include malaria-parasitized G6PDH-deficient erythrocytes where a high NADP ϩ /NADPH ratio prevails (32), human immunodeficiency virus-infected CD4 ϩ cells with millimolar concentrations of GSSG (34) , and in general, cells affected by severe malnutrition (35) or by oxidative stress (36 -38) .
With regard to MDS forms of GR, the physiologic inhibitor dinitrosyl-diglutathionyl iron complex can serve as a model. When reacting with EH 2 (FAD)(SH) 2 , one glutathione moiety of dinitrosyl-diglutathionyl iron complex forms the MDS with the interchange thiol, and concomitantly, the flavin-interacting thiol is irreversibly oxidized to the sulfinate level by the reacted dinitrosyl-diglutathionyl iron complex product. This model reaction, which has been confirmed by x-ray crystallography, suggests that modification of MDS species by oxidizing drugs leads to irreversible inactivation. In contrast, reaction of EH 2 species with oxidants would restore the E ox form (39, 40) .
EH 4 , which was found to occur when a high NADPH/NADP ϩ ratio was maintained by the G6PDH system (Fig. 6B, curve 7) , deserves further study because it appears to be the form of GR that is susceptible to degradation (27) . This suggests that the GR level in cells like malarial parasites which exhibit stagedependent changes in GR content is regulated via the EH 4 form.
In conclusion, MDS and EH 4 have been under-appreciated species. These species as well as the EH 2 (FAD)(SH) 2 ⅐NADPH complex must be considered in biomedical studies on glutathione reductases, in particular when considering P. falciparum GR as a target of rationally designed antimalarial drugs.
